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Abstract More than 40 years have passed since the original
publication by Hay£ick and Moorhead led to the concept of the
‘Hay£ick limit’ of the maximum number of divisions which
somatic cells undergo in vitro. This concept is still regarded
as a fundamental characteristic of species longevity. Here we
want to emphasize another characteristic of somatic cells,
namely, the duration of their survival in vitro in the non-dividing
state after cessation of proliferation. This is suggested on the
basis of results of recent experiments with so-called Japanese
accelerated senescent mice. Results of these experiments reveal
a good correlation between the longevity of the mice, the num-
ber of duplications of their ¢broblasts in vitro, and the survival
time of these cells in the non-dividing state. In routine culture
conditions, cell survival time may be very long, as much as a few
years. However, when the cells are grown under conditions of
oxidative stress, cellular longevity is markedly shortened. This
new test may serve as an additional marker of organismic lon-
gevity. The comparative value of both tests, the classical ‘Hay-
£ick limit’ and the new test, is discussed.
) 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Originally, cell senescence was considered to occur when
cell division in vitro decreased and then ceased, accompanied
by predictable and easily observable morphological changes
speci¢c for di¡erent cells [1]. Cells that completed their pro-
liferative life span and reached a terminal post-mitotic state
were referred to as being senescent. This de¢nition was de-
rived from the belief that the irreversible non-dividing state is
related to ageing of the organism [2]. The question about
probable relevance of cell senescence to organism ageing
[3,4] occupied researchers for many years and is still the sub-
ject of intensive discussions. Reactions to the problem of the
role played by cell senescence in human ageing have varied
from enthusiasm to skepticism.
More than a century ago, August Weismann postulated
that normal somatic cells senesce and cease to divide, whereas
germ and cancer cells do not [5]. He also suggested that cells
from long-living animal species can undergo a greater number
of divisions than cells derived from animals with a shorter life
span [6]. However, Weismann’s initial insight into cell ageing
was promptly and thoroughly ignored. For many years, a
dogma was accepted that animal cells in culture may prolif-
erate inde¢nitely. This belief in the immortality of germ cells
and all somatic cells was supported in the ¢rst half of the 20th
century by the well-known scientists Alexis Carrel and Albert
Eberling, who worked with cultured chicken cells [7].
It required remarkable courage for Leonard Hay£ick and
Paul Moorhead to suggest in 1961 [8] that cells have ‘life
spans’ and that the inde¢nite somatic cell proliferative longev-
ity reported by earlier researchers was due to technical errors
in their work. In recent years, the ‘Hay£ick limit’ has itself
become a dogma of modern cell biology.
2. Dependence of the cell proliferative life span in vitro on
organism longevity: experimental evidence pro and contra
It has been suggested that the behavior of cells in vitro
re£ects the ageing of the organism [9].
Four kinds of results favor such a proposal.
1. A limitation of the cell proliferative potential is seen not
only in vitro but also in vivo. In contrast to the immortal-
ity of germ cell lines, a limited number of divisions are
undergone by typical human somatic cells in vivo [10].
This restricted cell proliferation potential in vivo has
been con¢rmed by two kinds of experiments, one in which
serial transplantations of normal somatic cells were made
to young hosts [11], and another in which bone marrow
cells were transplanted to lethally irradiated mice [12].
2. A correlation exists between the life span of in vitro pro-
liferated ¢broblasts and donor longevity [13].
3. There is a decrease in ¢broblast proliferation life span as a
function of donor age [9,14^16].
4. A decrease in proliferative life span of ¢broblasts obtained
from patients with syndromes of premature ageing, such as
Werner’s [14,15,17^24].
In the 1990s, after experimental proof [25,26] of Alexei
Olovnikov’s fruitful marginotomy hypothesis [27], the key
role played by telomeres and telomerase in cell proliferation
control has been generally accepted. Proliferative potential
began to be indubitably connected to telomere length.
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Along with data supporting the connection between prolif-
erative potential and organismic longevity, there appeared a
number of facts which fell outside the frame of this assump-
tion.
It has been demonstrated that telomere length in a given
cell phenotype may depend on cell localization in the body,
and is therefore not directly dependent on the age of the
organism. Thus, the telomere length of endothelial cells de-
creases as a function of donor age. However, there is a greater
decline in telomere length with ageing in cells isolated from
the iliac artery, in comparison with cells from the thoracic
artery [28]. CD4+ T lymphocytes, CD8+ T lymphocytes,
and B lymphocytes all show telomere shortening with age,
although at di¡erent rates, and their mean telomere length
also di¡ers [29]. In the case of B cells, telomere lengths may
actually increase during both tonsillar B cell di¡erentia-
tion and the formation of germinal centers in lymphatic nodes
[30].
It has been demonstrated that various somatic cells have a
de¢ned replicative life span characteristic of the tissue from
which they are derived. Thus, if we estimate cell senescence as
the decline of the cycling fraction of cells per population dou-
bling, human dermal ¢broblasts and human peritoneal meso-
thelial cells show di¡erences (0.89% versus 2.2% per popula-
tion doubling, respectively) [31]. However, it is di⁄cult to
compare life spans of cells of di¡erent origin because they
grow in di¡erent media and we cannot exclude the in£uence
of media on their growth.
Attempts to revise the dependence of cell life span on donor
age and connect the proliferative potential in vitro with dis-
eases of the organism and the cell’s liability to damage have
been undertaken [32^34].
The proliferative potential of lymphocytes in Werner’s pre-
mature ageing syndrome is unchanged whereas that of ¢bro-
blasts decreases. There is an explanation of this observation.
In normal humans, lymphocytes retain the ability to regulate
telomerase activity in response to stimuli of proliferation. If
this occurs as well in Werner’s patients, their lymphocytes
should exhibit approximately normal proliferative life spans,
a prediction that is supported by experimental observations
[35].
There are serious di⁄culties in interpreting the interrela-
tionship between proliferative life span and organism longev-
ity among di¡erent animal species [36,37]. For instance,
among primates, humans have the longest life spans but the
shortest telomeres [38]. On the other hand, rodents have a
short life span and the longest telomeres [39,40]. Telomeres
are even longer in SCID mice [41]. A molecular mechanism
has been proposed to explain how telomeres of di¡erent
lengths may restrict cell proliferative potential [39].
In spite of all the di⁄culties and confusion, the assumption
about the connection of cell senescence and organismic ageing
has not been rejected. It is therefore reasonable to cite a short
section from Hay£ick’s lecture delivered in 1998 at a confer-
ence on telomeres. ‘‘We suggested the Phase III Phenomenon
(the period in which cell replication diminished and stopped)
was the manifestation of ageing at the cellular level. Quite
frankly, I expected that this idea would be disproved quickly,
but I think it is fair to say that of the thousands of papers
published in this ¢eld in the last 35 years, which I subse-
quently named cytogerontology, none have disproved this
suggestion’’ [4].
3. Dependence of proliferative life span in vitro on organism
longevity: theoretical considerations pro and contra
The most obvious mechanism in animals for maintenance
of life is the ability to repair external and internal damage of
tissues. In addition to tissue repair, there is also a continual
replacement of most cells, as in skin epidermis and gut lining.
This latter process involves the replacement of disposable cells
and those lost during wear and tear. The maintenance and
survival of the adult organism are completely dependent on
a normal immune response, which, in turn, is fully dependent
on cell proliferation. Consequently, adult body maintenance
requires a well-organized planned and extraordinary expendi-
ture of cells that is related to the longevity of the organism.
This means that proliferative potential (pp) should be a func-
tion of the organism’s longevity:
2ppWlongevity
On further re£ection, it is clear that other factors modulate
the original consideration described above and change its
character. Four main factors are given here.
1. As the organism becomes larger, the planned and extraor-
dinary cell numbers should necessarily increase.
2. A limitation of the proliferative potential may (or may not)
serve as a defense mechanism against cancer [42,43]. This
mechanism is less important (if it is important at all) in
short-living species [44]. Repression of telomerase in the
somatic tissues of humans, and probably other long-lived
mammals, appears to have evolved as a powerful protective
barrier against cancer [45^47].
3. In the course of ontogenesis, a repression of telomerase
activity takes place in somatic cells. In fact, only from
that moment we can speak about the limitation of cell
proliferation. However, the tissue stem cells retain some
reduced level of telomerase activity in the adult body.
The concentration of such stem cells may di¡er in di¡erent
species. The stem cell division rate may also be di¡erent as
well as the regulation of their telomerase activity [44].
The role of telomerase in stem cells was ¢rst identi¢ed
within the hematopoietic system [48]. Telomerase is in-
duced in hematopoietic stem cells by cytokine stimulation
and is down-regulated again with proliferation and di¡er-
entiation [49]. The presence of stem cells capable of ex-
pressing telomerase upon stimulation results in a slower
overall rate of ageing in the immune system [50].
The telomerase activity can be reactivated not only in stem
cells. Some cells of the immune system and even ¢broblasts
and endothelial cells in the course of regeneration reacti-
vate telomerase [51].
4. The technology used routinely to determine proliferative
life span is itself open to criticism. Due to great technical
di⁄culties in watching a single cell grow, the proliferation
potential is usually measured as the number of population
doublings. One problem is that the ¢nal value of prolifer-
ative potential is to a large extent based on a single most
long-lived cell. This value may vary signi¢cantly, depend-
ing largely on selection and the size of the biopsy.
All of the considerations enumerated above complicate a
thorough understanding of the interrelationship between cell
proliferation potential and organism longevity. This hampers
the use of the proliferative life span test in studying the nature
and mechanism of ageing. This limitation is a stimulus for
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examining other cellular characteristics that may serve as ad-
ditional tests of ageing.
4. The role of post-mitotic cells in body maintenance
Any multicellular organism consists of dividing and non-
dividing cells. Both their ability to divide and their ability for
long-term life without division should be very important fac-
tors that determine organism longevity. Ageing is the result of
natural selection [52^54] and all systems created by natural
selection should be equally reliable, like the parts of a plane,
to maintain the organism’s life. If longevity of an organism
depends on the proliferative potential and the survival time of
non-dividing cells, these two parameters should correspond to
each other.
In recent experiments [40] on the cells of so-called Japanese
senescent accelerated mice, quite a good correlation between
the mouse’s longevity, the embryo ¢broblast life spans in vitro
and the time of senesced non-dividing ¢broblast survival in
culture was found (Fig. 1). A correlation between the organ-
ism’s longevity and erythrocyte survival time was reported
previously [55].
It is interesting to mention that both organism longevity
and survival time of senescent non-dividing ¢broblasts is
greater in humans as compared with mice. These data suggest
that the time of senescent ¢broblast survival in vitro in the
non-dividing state may be regarded as a di¡erent in vitro test
of the organism’s lifetime in vivo, in addition to Hay£ick’s
characteristics.
A test for evaluation of cell survival in stationary cultures
was suggested some time ago [56^58]. However, this test is
rather di⁄cult to interpret as the culture conditions during
the experiment may undergo variable unpredictable changes.
A serious di⁄culty in using our suggested test may be con-
nected with the long time of cell survival in culture of human
cells, as long as years [59]. This problem may be overcome by
growing cells under conditions of oxidative stress. It has been
shown that the addition of hydrogen peroxide to the culture
medium reduces the survival time, thus making it more prac-
tical to employ the test in investigations of organism ageing
[60].
5. Comparison of two di¡erent cellular tests to describe
organism longevity
The eventual outcome of cell senescence is cell death (Fig.
2). It can be seen that each of the previously discussed tests is
pertinent to a di¡erent aspect of cell life, active proliferation
and the non-dividing state. Both tests therefore re£ect the
process of cell senescence.
Results of the comparison of both tests are given in Ta-
ble 1.
Each test has its own advantages and disadvantages, but
the second test that we are directing attention to in this re-
view, duration of senescent ¢broblast survival, has fewer dis-
advantages than the ¢rst test, proliferative potential of ¢bro-
blasts.
Some of these characteristics require a more detailed dis-
cussion. There are some available data [61,62] making it pos-
sible to attribute ¢broblasts to typical di¡erentiated cells such
as hepatocytes, leukocytes, neurons, or myocytes. A peculiar-
ity of ¢broblasts is that damage can be a factor inducing their
di¡erentiation [62]. Furthermore, ¢broblast di¡erentiation
with subsequent survival in a non-proliferative state is more
independent of various external factors than that of many
other di¡erentiated cells. For example, cardiomyocytes cru-
cially depend on the coronary arteries for their survival.
They undergo little direct tissue ageing [63], and their survival
time is probably determined by the senescence of endothelial
cells lining the arterial walls. Neuron survival depends on
both endothelial and glial cells.
Regarding ¢broblasts, their survival in vivo is mainly self-
determined. Fibroblasts participate in tissue repair and live
mainly in irregular conditions. The length of their life in the
non-dividing state is determined by intrinsic abilities to carry
out repair functions after damage and survive under unfavor-
able conditions. Therefore, an organism from a long-lived
species would be expected to have post-mitotic ¢broblasts
that are likewise long-lasting. It may thus be concluded that
¢broblast survival time in vitro is a good re£ection of organ-
ism longevity. It does not depend either on the organism’s
body size, on the anti-cancer defense mechanisms, or on the
tissue stem cell distribution and telomerase regulation (Ta-
ble 1).
Ordinarily, when investigators examine the longevity of
proliferating ¢broblasts in vitro, they do not take into account
the fact that the cells are growing in an oxygen concentration
Fig. 1. Correlation of mouse longevity with proliferative potentials
of the ¢broblasts and survival time of senescent non-dividing cells.
Table 1
Comparison of the two characteristics of cell senescence
Proliferative potential of ¢broblasts Duration of senescent ¢broblast survival
Should be dependent on longevity
Should be dependent on stress (in vitro culture conditions)
Should be dependent on animal size No apparent dependence on animal size
Can be restricted or not due to anti-cancer defense No apparent dependence on anti-cancer defense
Should be dependent on tissue stem cell distribution and telomerase
regulation
No apparent dependence on tissue stem cell distribution and telomerase
regulation
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several times greater than in vivo. This means that cultivated
¢broblasts are actually growing under conditions of oxidative
stress. When the oxygen concentration in culture is reduced,
there is a resultant increase in cell life [64,65]. As was men-
tioned above, the duration of survival of senesced cells is also
dependent on the oxidative stress [60]. This fact to a certain
degree serves to unite the ¢broblast life span and the survival
tests.
We therefore conclude that the parallel use of both cellular
tests discussed in this paper enlarges the possibilities of study-
ing the longevity of organisms as well as illuminating the
nature of ageing.
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